لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, California., Wortman JR; Seres Therapeutics, Cambridge, Massachusetts., Burton EM; Strategic Translational Research Initiative Development, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alayli FA; Parker Institute for Cancer Immunotherapy, San Francisco, California., Loo CP; Parker Institute for Cancer Immunotherapy, San Francisco, California., Gautam S; Parker Institute for Cancer Immunotherapy, San Francisco, California., Damania A; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., Densmore J; Parker Institute for Cancer Immunotherapy, San Francisco, California., Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Portage Biotech, Westport, Connecticut., Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California., Wong MC; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Weiner B; Seres Therapeutics, Cambridge, Massachusetts., Hicks N; Seres Therapeutics, Cambridge, Massachusetts., Aunins J; Seres Therapeutics, Cambridge, Massachusetts., McChalicher C; Seres Therapeutics, Cambridge, Massachusetts., Walsh E; Seres Therapeutics, Cambridge, Massachusetts., Tetzlaff MT; Department of Pathology, University of California San Francisco, San Francisco, California., Hamid O; Cutaneous Oncology, The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Boland GM; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Sullivan RJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Grossmann KF; Providence Cancer Institute Franz Clinic, Portland, Oregon., Ajami NJ; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., LaVallee T; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Coherus BioSciences, Redwood City, California., Henn MR; Seres Therapeutics, Cambridge, Massachusetts., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

المصدر: Cancer discovery [Cancer Discov] 2024 Jul 01; Vol. 14 (7), pp. 1161-1175.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Multicenter Study

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Gastrointestinal Microbiome*/drug effects , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/pharmacology, Humans ; Female ; Male ; Middle Aged ; Aged ; Immune Checkpoint Inhibitors/therapeutic use ; Nivolumab/therapeutic use ; Nivolumab/administration & dosage ; Biomarkers, Tumor ; Vancomycin/therapeutic use ; Adult ; COVID-19/immunology ; Skin Neoplasms/drug therapy ; Skin Neoplasms/immunology

المؤلفون: Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Surgery, University of Washington, Seattle., Pollack SM; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

المصدر: JAMA oncology [JAMA Oncol] 2024 Jun 01; Vol. 10 (6), pp. 830-831.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma*/therapy , Sarcoma*/pathology, Humans ; Soft Tissue Neoplasms/therapy ; Soft Tissue Neoplasms/pathology ; Soft Tissue Neoplasms/secondary ; Radioimmunotherapy/methods ; Neoplasm Metastasis

المؤلفون: Pothuri VS; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA., Hogg GD; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Conant L; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA., Borcherding N; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., James CA; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA., Mudd J; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA., Williams G; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA., Seo YD; Department of Surgery, University of Washington School of Medicine, Seattle, WA, USA.; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Hawkins WG; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO USA., Pillarisetty VG; Department of Surgery, University of Washington School of Medicine, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA USA., DeNardo DG; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO USA., Fields RC; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO USA.

المصدر: Oncoimmunology [Oncoimmunology] 2024 Mar 15; Vol. 13 (1), pp. 2320411. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/diagnosis , Pancreatic Neoplasms*/genetics , Carcinoma, Pancreatic Ductal*/diagnosis , Carcinoma, Pancreatic Ductal*/genetics, Humans ; T-Lymphocytes ; Receptors, Antigen, T-Cell/genetics ; Biomarkers

المؤلفون: Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Surgery, University of Washington, Seattle., Lu H; Seagen Inc, Bothell, Washington., Black G; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Smythe K; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Yu Y; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Hsu C; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle., Ng J; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle.; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Hermida de Viveiros P; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Warren EH; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle., Schroeder BA; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., O'Malley RB; Department of Radiology, University of Washington, Seattle., Cranmer LD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle., Loggers ET; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle., Wagner MJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle., Bonham L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Pillarisetty VG; Department of Surgery, University of Washington, Seattle., Kane G; Department of Radiation Oncology, University of Washington, Seattle., Berglund P; HDT Bio, Seattle, Washington., Hsu FJ; Apexigen, San Carlos, California., Mi X; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Alexiev BA; Department of Pathology, Northwestern University, Chicago, Illinois., Pierce RH; Sensei Biotherapeutics Inc, Boston, Massachusetts., Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Jones RL; Royal Marsden and Institute for Cancer Research, London, UK., Ter Meulen J; Obsidian Therapeutics, Cambridge, Massachusetts., Kim EY; Department of Radiation Oncology, University of Washington, Seattle., Pollack SM; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

المصدر: JAMA oncology [JAMA Oncol] 2023 Dec 01; Vol. 9 (12), pp. 1660-1668.

نوع المنشور: Controlled Clinical Trial; Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Soft Tissue Neoplasms*/drug therapy , Soft Tissue Neoplasms*/radiotherapy , Sarcoma*/drug therapy , Sarcoma*/radiotherapy, Humans ; Female ; Aged ; Male ; Toll-Like Receptor 4/agonists ; T-Lymphocytes ; Receptors, Antigen, T-Cell

المؤلفون: Zhang X; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Institute for Translational Epidemiology & Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Irajizad E; Division of Basic Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hoffman KL; Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA., Fahrmann JF; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Cancer Prevention and Population Sciences, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li F; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Seo YD; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Browman GJ; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dennison JB; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vykoukal J; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Luna PN; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Siu W; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu R; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Murage E; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ajami NJ; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McQuade JL; Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo JA; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Long JP; Division of Basic Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Do KA; Division of Basic Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lampe JW; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Basen-Engquist KM; Division of Cancer Prevention and Population Sciences, Department of Heath Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Okhuysen PC; Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kopetz S; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hanash SM; Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Cancer Prevention and Population Sciences, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Petrosino JF; Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA., Scheet P; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daniel CR; Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: cdaniel@mdanderson.org.

المصدر: EBioMedicine [EBioMedicine] 2023 Dec; Vol. 98, pp. 104873. Date of Electronic Publication: 2023 Nov 30.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

مواضيع طبية MeSH: Prebiotics* , Gastrointestinal Microbiome*, Humans ; Proteomics ; Obesity/microbiology ; Inflammation

المؤلفون: Cass SH; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Tobin JWD; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Seo YD; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Gener-Ricos G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston., Keung EZ; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Burton EM; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Davies MA; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., McQuade JL; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Lazar AJ; Departments of Pathology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, USA., Mason R; Gold Coast University Hospital, Southport., Millward M; University of Western Australia, Perth., Sandhu S; Peter Macallum Cancer Centre, Melbourne., Khoo C; Peter Macallum Cancer Centre, Melbourne., Warburton L; Fiona Stanley Hospital, Perth; Edith Cowan University, Joondalup; Future Health Research and Innovation Fund/Raine Clinician Research Fellowship., Guerra V; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston., Haydon A; Alfred Hospital, Melbourne., Dearden H; Melanoma Institute Australia, The University of Sydney, Sydney., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney; Westmead Hospital, Sydney, Australia., Smith JL; Westmead Hospital, Sydney, Australia., Mollee P; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Burgess M; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Mapp S; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Keane C; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Atkinson V; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Parikh SA; Mayo Clinic, Rochester, USA., Markovic SN; Mayo Clinic, Rochester, USA., Ding W; Mayo Clinic, Rochester, USA., Call TG; Mayo Clinic, Rochester, USA., Hampel PJ; Mayo Clinic, Rochester, USA., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney., Wargo JA; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jwargo@mdanderson.org., Ferrajoli A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Sep; Vol. 34 (9), pp. 796-805. Date of Electronic Publication: 2023 Jul 04.

نوع المنشور: Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/complications , Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Melanoma*/pathology, Adult ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Australia ; Progression-Free Survival ; Retrospective Studies

المؤلفون: Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ajami N; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.

المصدر: Nature medicine [Nat Med] 2023 Aug; Vol. 29 (8), pp. 1910-1911.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Gastrointestinal Tract* , Neoplasms*/therapy, Humans